Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

Upon a pre-specified, interim analysis after nine months of treatment, the company said sibeprenlimab therapy was associated with a “statistically significant and clinically meaningful” reduction, ...

No. 2 North Dakota State won the 2024 Dakota Marker, defeating No. 1 South Dakota State 13-9. With the win, the Bison end a five-game losing streak to the Jackrabbits. North Dakota State ...

SMN2 is a biomarker for SMA severity but not for treatment response, highlighting the need for additional markers like TSP4. TSP4 levels increased after nusinersen therapy, indicating potential as ...